MUC4 and neoplasm: Studies have shown that the expression of MUC4 is incrementally increased during the progression of pancreatic cancer and correlates with the activation of Wnt/β-catenin signaling pathways, which are known to interact with MUC4 and contribute to the modulation of the tumor microenvironment.